These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 4567283)

  • 41. Expression of HLA-DR antigens by colonic epithelium in inflammatory bowel disease.
    Selby WS; Janossy G; Mason DY; Jewell DP
    Clin Exp Immunol; 1983 Sep; 53(3):614-8. PubMed ID: 6577996
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Serum lymphocytotoxic and lymphocytophilic antibody activity in inflammatory bowel disease.
    Korsmeyer S; Strickland RG; Wilson ID; Williams RC
    Gastroenterology; 1974 Oct; 67(4):578-83. PubMed ID: 4607065
    [No Abstract]   [Full Text] [Related]  

  • 43. Carcino-embryonic antigen levels in inflammatory disease of the large bowel.
    Wight DG; Gazet JC
    Proc R Soc Med; 1972 Nov; 65(11):967-8. PubMed ID: 4642026
    [No Abstract]   [Full Text] [Related]  

  • 44. Monoclonal B lymphocytes in the peripheral blood of patients with inflammatory bowel disease.
    Ginsburg CH; Ault KA; Falchuk ZM
    Gastroenterology; 1981 Dec; 81(6):1111-4. PubMed ID: 7026345
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [The immunology of inflammatory bowel disease (author's transl)].
    Bartnik W; Shorter RG
    Przegl Lek; 1981; 38(6):481-9. PubMed ID: 7268048
    [No Abstract]   [Full Text] [Related]  

  • 46. Cellular hypersensitivity to intestinal mucosa components in ulcerative colitis and Chrohn's disease.
    Bendixen G
    Tijdschr Gastroenterol; 1970; 13(6):459-66. PubMed ID: 5519339
    [No Abstract]   [Full Text] [Related]  

  • 47. Imparied lymphocyte responsiveness in inflammatory bowel disease.
    Sachar DB; Taub RN; Brown SM; Present DH; Korelitz BI; Janowitz HD
    Gastroenterology; 1973 Feb; 64(2):203-9. PubMed ID: 4405597
    [No Abstract]   [Full Text] [Related]  

  • 48. [Role of lymphocytes in the development of tissue damage in ulcerative colitis].
    Bakowska Z; Bartnik W
    Pol Tyg Lek; 1971 Aug; 26(33):1290-3. PubMed ID: 4937518
    [No Abstract]   [Full Text] [Related]  

  • 49. Cd1d-restricted cellular lysis by peripheral blood lymphocytes: relevance to the inflammatory bowel diseases.
    Page MJ; Poritz LS; Tilberg AF; Zhang WJ; Chorney MJ; Koltun WA
    J Surg Res; 2000 Aug; 92(2):214-21. PubMed ID: 10896824
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Crypt hyperplasia related to increased lymphocyte activation in the rectal mucosa of children with ulcerative colitis.
    Arato A; Savilahti E; Paszti I
    Z Gastroenterol; 1994 Sep; 32(9):483-7. PubMed ID: 7801653
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Natural killer cell function and lymphocyte subpopulation profiles in inflammatory bowel disease.
    Brown TE; Bankhurst AD; Strickland RG
    J Clin Lab Immunol; 1983 Jul; 11(3):113-7. PubMed ID: 6224936
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Pokeweed mitogen stimulated immunoglobulin production by peripheral blood lymphocytes in vitro: evidence for disordered immunoregulation in patients with ulcerative colitis and Crohn's disease.
    Danis VA; Heatley RV
    Clin Exp Immunol; 1983 Dec; 54(3):739-46. PubMed ID: 6606515
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Pathogenetic models ulcerative colitis and Crohn disease].
    Feller AC; Löhler J; Reimann J; Merz H
    Verh Dtsch Ges Pathol; 1996; 80():104-8. PubMed ID: 9064992
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Immunology of inflammatory bowel disease--an update.
    Jewell DP
    J Gastroenterol; 1995 Nov; 30 Suppl 8():78-82. PubMed ID: 8563898
    [No Abstract]   [Full Text] [Related]  

  • 55. Alteration in T lymphocyte subpopulations in inflammatory bowel disease.
    Victorino RM; Hodgson HJ
    Clin Exp Immunol; 1980 Jul; 41(1):156-65. PubMed ID: 6969150
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Colicinogens in nonspecific intestinal inflammations. II. Test of leukocyte migration inhibition with colicins].
    Bures J; Horák V; Buresová E; Fixa B; Komárková O
    Cesk Gastroenterol Vyz; 1983 Apr; 37(3):186-90. PubMed ID: 6347404
    [No Abstract]   [Full Text] [Related]  

  • 57. Phagocytosis, killing, lymphocyte-mediated antibacterial activity, serum autoantibodies, and plasma endotoxins in inflammatory bowel disease.
    Caradonna L; Amati L; Lella P; Jirillo E; Caccavo D
    Am J Gastroenterol; 2000 Jun; 95(6):1495-502. PubMed ID: 10894586
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The role of cellular immunity in neoplasia.
    Glade PR; Zaldivar NM; Mayer L; Cahill LT
    Pediatr Res; 1976 May; 10(5):517-22. PubMed ID: 778771
    [No Abstract]   [Full Text] [Related]  

  • 59. Further studies on in vitro cytotoxicity of lymphocytes from patients with ulcerative and granulomatous colitis for allogeneic colonic epithelial cells, including the effects of colectomy.
    Shorter RG; Cardoza M; Spencer RJ; Huizenga KA
    Gastroenterology; 1969 Feb; 56(2):304-9. PubMed ID: 5764597
    [No Abstract]   [Full Text] [Related]  

  • 60. Disparate CD4+ lamina propria (LP) lymphokine secretion profiles in inflammatory bowel disease. Crohn's disease LP cells manifest increased secretion of IFN-gamma, whereas ulcerative colitis LP cells manifest increased secretion of IL-5.
    Fuss IJ; Neurath M; Boirivant M; Klein JS; de la Motte C; Strong SA; Fiocchi C; Strober W
    J Immunol; 1996 Aug; 157(3):1261-70. PubMed ID: 8757634
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.